Andrew J. Ullmann

2000–2022 年に発表

69
論文数
22,711
被引用数
67
h 指数
69
i10 指数

被引用数

Andrew J. Ullmann の年別被引用数1991 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 3 件2004 年: 被引用 7 件2005 年: 被引用 20 件2006 年: 被引用 17 件2007 年: 被引用 85 件2008 年: 被引用 113 件2009 年: 被引用 92 件2010 年: 被引用 122 件2011 年: 被引用 104 件2012 年: 被引用 99 件2013 年: 被引用 115 件2014 年: 被引用 162 件2015 年: 被引用 147 件2016 年: 被引用 221 件2017 年: 被引用 191 件2018 年: 被引用 214 件2019 年: 被引用 786 件2020 年: 被引用 734 件2021 年: 被引用 771 件2022 年: 被引用 492 件2023 年: 被引用 395 件2024 年: 被引用 632 件2025 年: 被引用 272 件2026 年: 被引用 2 件1992〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,361 件、この内訳の 17%ドイツ: 引用元論文 571 件、この内訳の 7.2%フランス: 引用元論文 484 件、この内訳の 6.1%イギリス: 引用元論文 480 件、この内訳の 6%イタリア: 引用元論文 382 件、この内訳の 4.8%スペイン: 引用元論文 378 件、この内訳の 4.7%オランダ: 引用元論文 308 件、この内訳の 3.9%中国: 引用元論文 304 件、この内訳の 3.8%インド: 引用元論文 262 件、この内訳の 3.3%オーストラリア: 引用元論文 259 件、この内訳の 3.2%オーストリア: 引用元論文 236 件、この内訳の 3%スイス: 引用元論文 234 件、この内訳の 2.9%
0%17%その他 34.1%

分野

  • Medicine86.7%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Immunology and Microbiology3.5%
  • Engineering0.6%
  • Computer Science0.6%
  • Agricultural and Biological Sciences0.5%
  • その他2.6%

トピック

  • Antifungal resistance and susceptibility20.4%
  • Fungal Infections and Studies13.9%
  • Cytomegalovirus and herpesvirus research4.1%
  • Pneumocystis jirovecii pneumonia detection and treatment3%
  • Neutropenia and Cancer Infections2.8%
  • Herpesvirus Infections and Treatments2.2%
  • その他53.6%

共著者

全論文

検索で開く
  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claus Peter Heußel, C Kibbler, Н Н Климко, Bart Jan Kullberg, Christoph Lange, Thomas Lehrnbecher, Jürgen Löffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Jacques F. Meis, Livio Pagano, Patricia Ribaud, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Maurizio Sanguinetti, Donald C. Sheppard, János Sinkó, Anna Skiada, Maria J. G. T. Vehreschild, Claudio Viscoli, Oliver A. Cornely - Clinical Microbiology and Infection 2018 被引用: 1,518

  2. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús Guinea, Claus Peter Heußel, Ashraf S. Ibrahim, Souha S. Kanj, Н Н Климко, Michaela Lackner, Frédéric Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong‐Gun Lee, Thomas Lehrnbecher, B. Lmimouni, Mihai Mareș, Georg Maschmeyer, Jacques F. Meis, Joseph Meletiadis, C. Orla Morrissey, Márcio Nucci, Rita Oladele, Livio Pagano, Alessandro C. Pasqualotto, Atul Patel, Zdeněk Ráčil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinkó, Anna Skiada, Monica A. Slavin, Rajeev Soman, Brad Spellberg, William J. Steinbach, Ban Hock Tan, Andrew J. Ullmann, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild, Thomas J. Walsh, P. Lewis White, Nathan P. Wiederhold, Theoklis E. Zaoutis, Arunaloke Chakrabarti - The Lancet Infectious Diseases 2019 被引用: 1,756

  3. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,206

  4. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 972

  5. ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

    著者: , , , , , , , , , , , , , - Clinical Microbiology and Infection 2015 被引用: 784

  6. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 被引用: 1,214

  7. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

    著者: , , , , , , , , - European Respiratory Journal 2015 被引用: 1,012

  8. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 1,807

  9. Evolving epidemiology of pneumocystis pneumonia: Findings from a longitudinal population-based study and a retrospective multi-center study in Germany

    著者: , , , , , , - The Lancet Regional Health - Europe 2022 被引用: 87

  10. ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 被引用: 362

  11. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 1,336

  12. Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2007 被引用: 744

  13. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 被引用: 395

  14. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shallu Kathuria, Olivier Lortholary, Jacques F. Meis, Andrew J. Ullmann, G. Petrikkos, Cornelia Lass‐Flörl - Clinical Microbiology and Infection 2014 被引用: 511

  15. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew J. Ullmann, Anne van Diepeningen, Paul E. Verweij, G. Petrikkos - Clinical Microbiology and Infection 2014 被引用: 858

  16. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 被引用: 689

  17. Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 371

  18. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Maria Tortorano, Andrew J. Ullmann, Paul E. Verweij, Oliver A. Cornely, Manuel Cuenca‐Estrella - Clinical Microbiology and Infection 2014 被引用: 362

  19. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

    著者: , , , , , , , , , , , , , - Annals of Hematology 2016 被引用: 211

  20. Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    著者: , , , , , , , , , , , , , , , , , , , , , - Mycoses 2020 被引用: 72

  21. ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 被引用: 335

  22. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Hematology 2017 被引用: 215

  23. Forty-one recent cases of invasive zygomycosis from a global clinical registry

    著者: , , , , , , , , , , , , , , , , , , - Journal of Antimicrobial Chemotherapy 2009 被引用: 201

  24. Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries

    著者: , , , , , , , , , , , , , , , , , , , , - Haematologica 2013 被引用: 122